PSA screening for prostate cancer reduces disease-specific deaths, new review shows
Stat News • 5/15/2026
Summary
A new review indicates that prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer. The findings suggest that PSA screening may lower disease-specific mortality rates.
Advertisement
Lindy Score Breakdown (V4.2)
8h
Age
1
Sources
from cluster
3
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier96% (0.5^3/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Three years of declining overdose deaths begets cautious optimism and some concerns
Stat News • Today
U.S. overdose deaths fell again in 2025, but some worry about policy and drug supply changes
Stat News • 1 day ago
STAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission
Stat News • 1 day ago
Makary’s departure and Cassidy’s tenuous Senate seat
Stat News • Today
Supreme Court preserves access to widely used abortion pill, while lawsuit plays out
Stat News • Today
STAT+: The hunt for FDA’s next leader
Stat News • Today
STAT+: Pharmalittle: We’re reading about upbeat results for a Duchenne drug, Takeda layoffs, and much more
Stat News • Today
STAT+: AI medical devices’ dirty FDA secret
Stat News • 1 day ago
STAT+: Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage study
Stat News • Today
STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
Stat News • 1 day ago
